Turn Therapeutics Inc. TTRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.45M | -3.84M | -- | -- | -- |
| Total Depreciation and Amortization | 56.90K | 54.90K | -- | -- | -- |
| Total Amortization of Deferred Charges | 1.23M | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.18M | -2.05M | -- | -- | -- |
| Change in Net Operating Assets | 1.65M | 1.94M | -- | -- | -- |
| Cash from Operations | -4.32M | -3.90M | -- | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -139.20K | -165.20K | -- | -- | -- |
| Cash from Investing | -139.20K | -165.20K | -- | -- | -- |
| Total Debt Issued | 6.72M | 6.72M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.84M | 6.99M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.56M | 13.71M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.10M | 9.65M | -- | -- | -- |